Advertisement

Readers like you keep news free for everyone.

More than 5,000 readers have already pitched in to keep free access to The Journal.

For the price of one cup of coffee each week you can help keep paywalls away.

Support us today
Not now
Wednesday 8 February 2023 Dublin: 5°C

# Johnson and Johnson

Last year
2022
# Johnson and Johnson
Johnson & Johnson to replace talc baby powder with cornstarch-based alternative next year
The pharmaceutical giant has forked out billions in payouts to customers who said the talc was contaminated with asbestos.
# Johnson and Johnson
US drug regulator limits use of J&J Covid vaccine
The single shot vaccine is less protective than those developed by Pfizer and Moderna.
All time
# Johnson and Johnson
Supplies 'very limited' as pharmacies begin vaccinating 18-34 age group
The HSE confirmed that another 343,000 vaccine doses were administered last week.
# vaccine rollout
Six months into 2021, how close is Ireland to vaccinating 80% of the population?
This week marked the six-month mark in the vaccine rollout.
# vaccine rollout
HSE chief says there are 'some concerns' over delivery schedules of J&J jab
The HSE has not yet received delivery dates for the J&J vaccine in June.
# Vaccines
People in their 40s set to get choice of AstraZeneca and J&J, or wait for mRNA vaccine
The HSE’s Colm Henry said the latest vaccine administration advice was received over the weekend.
# Positive Moves
US health officials lift suspension of Johnson & Johnson Covid jab
Fifteen cases of blood clots were uncovered among nearly eight million vaccinations.
# Covid-19
NIAC to meet to discuss advice on Johnson & Johnson vaccine as hospital numbers remain stable
The single-shot vaccine is seen as crucial to Ireland’s rollout.
# one-shot vaccine
EU regulator says unusual blood clots should be listed as 'very rare side effect' of J&J vaccine
The European Medicines Agency said that the “overall benefits” of the vaccine in preventing Covid-19 outweigh the risks of side effects.
Unusual blood clots should be listed as "very rare side effects" - but the "overall benefits" of the vaccine in preventing Covid-19 outweigh the risks.
Eight rare blood clots with low levels of blood platelets were recorded among over 7 million doses of the J&J vaccine administered in the US.
The statement by the EMA is similar to its conclusion for the Oxford-AstraZeneca vaccine - which NIAC decided to limit to those aged over 60.
EMA decision on Johnson & Johnson will influence whether Ireland spaces out Pfizer vaccine doses
# European Medicines Agency
EMA decision on Johnson & Johnson will influence whether Ireland spaces out Pfizer vaccine doses
It follows concerns that the vaccine could be linked to extremely rare blood clots.
# one shot dose
Decision on J&J one-shot dose expected on Tuesday as EMA assesses blood clot data
The rollout of the one-shot dose was paused in the United States after six rare blood clots were identified post-vaccination.
# janssen
Johnson & Johnson postpones rollout of its vaccines to Europe as it reviews possible blood clot issue
Six cases of a rare blood clot have been reported out of 6.8 million doses of the vaccine administered in the US.
# Explainer
Explainer: Here's what we know about Johnson & Johnson's one-dose vaccine
The vaccine is expected to get the green light from the EU regulator on Thursday.
# Lawsuit
Australian court upholds lawsuit against J&J for 'negligent' marketing of pelvic mesh implants
Worldwide, more than two million women have had the mesh products implanted in their bodies.
# Vaccines
Johnson & Johnson single dose Covid vaccine cleared by US officials
J&J also is seeking authorisation for emergency use of its vaccine in Europe and from the World Health Organisation.
# you only get one shot
US set to approve Johnson & Johnson Covid vaccine
The European Medicines Agency is expected to approve the Johnson & Johnson vaccine for use in the European Union in early March.
# emergency approval
Johnson & Johnson applies for approval for one-dose Covid-19 vaccine in America
A recent study showed that the vaccine was 66% effective at preventing moderate to severe Covid-19.
# Vaccination
Johnson & Johnson expects to report Covid-19 vaccine results next week
The vaccine is a one-dose shot.
# pelvic mesh
Johnson & Johnson found 'negligent' in pelvic mesh lawsuit in Australia
Lawyers for the women said the devices caused “incontinence, infection and chronic pain”.
# Asbestos
Johnson & Johnson recalls 33,000 bottles of baby powder in US over asbestos concerns
The recalled lot consists of bottles which were distributed last year.
# Johnson and Johnson
Explainer: Why a US court ruling could be a turning point in one of the country's worst-ever drug epidemics
A landmark ruling against Johnson & Johnson was made in Oklahoma yesterday.
# compensation
Johnson and Johnson ordered to pay $4.69 billion damages in talcum powder cancer case
The plaintiffs said using the talc for personal hygiene had caused ovarian cancer.
# California
Johnson & Johnson ordered to pay woman €350m in cancer lawsuit
The woman claimed she developed terminal ovarian cancer after using the company’s talc-based products.
# Show Me The Money
These 11 companies control almost everything you buy
A small number of organisations have a whole lot of control – and revenue.
# Johnson and Johnson
Latest wind turbines for multinationals in Cork harbour energy project switched on
Two wind turbines are hoped to reduce costs at Johnson and Johnson plants in the area.
# Bad to worse
Zach attack as Johnson leads The Open but McIlroy slumps to +8
Migual Angel Jimenéz stormed into an early lead but remains in the mix despite dropping two late shots.
# Jobswatch
Contact lens manufacturer creates 100 jobs in Limerick
Vistakon Ireland, which designs and makes Avucue contact lenses, will also create an additional 200 temporary construction jobs.
# The Daily Fix
The Daily Fix: Wednesday
All the news of the day, plus some bits and pieces you may have missed…